Akebia Therapeutics | AKBA - 销售收入



金融业
股票价格
USD
资产
USD 362.52M
现金及等价物
USD 162.64M
销售成本
USD 10.34M
流动资产
USD 243.48M
流动负债
USD 173.88M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 27.38M
销售毛利
USD 47.28M
债务利息支出
362.52M
贷款资金
USD 36.4M
市值
USD 251.2M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13M
贸易债权人
USD 8.39M
应收帐款人
USD 47.03M


销售 更改 日
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amgen USD 8.62B 1.28B 2026-03
Ardelyx USD 94.47M 30.74M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 11.44B 1.78B 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
J&J USD 24.1B 500M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 389M 289M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pharma Mar EUR 42.9M 47.3M 2026-03
Prothena USD 51.08M 51.06M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03